Insider Trading activities at Vor Biopharma Inc. (VOR)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Vor Biopharma Inc. (VOR) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Vor Biopharma Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1817229.

Total stock buying since 2021: $73,632,168.
Total stock sales since 2021: $48,000,765.
Total stock option exercises since 2021: $23,726.


6 insiders reported insider trading activities at Vor Biopharma Inc. (VOR):
Insider trading activities of Attar Eyal C.
Insider trading activities of Chakraborty Tirtha
Insider trading activities of Parmar Kush
Insider trading activities of Hoffman Reid
Insider trading activities of Shah Rajeev M.
Insider trading activities of Schwab Andrew J.

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Vor Biopharma Inc. (VOR).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 0 $0 5,686,461 $37,847,890 0 $0
2024 0 $0 24,979 $33,273 0 $0
2021 4,090,676 $73,632,168 661,412 $10,119,602 17,446 $23,726

Table 2. Monthly summary of insider trading at Vor Biopharma Inc. (VOR).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-10 0 $0 898,643 $28,733,855 0 $0
2025-09 0 $0 2,695,730 $4,850,784 0 $0
2025-08 0 $0 2,089,534 $4,259,753 0 $0
2025-02 0 $0 2,554 $3,498 0 $0
2024-12 0 $0 10,334 $12,917 0 $0
2024-06 0 $0 14,645 $20,356 0 $0
2021-11 0 $0 661,412 $10,119,602 0 $0
2021-08 0 $0 0 $0 17,446 $23,726
2021-02 4,090,676 $73,632,168 0 $0 0 $0

Table 3. Detailed insider trading at Vor Biopharma Inc. (VOR)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-10-17 Shah Rajeev M. Sale 260,859 30.13 7,860,464
2025-10-16 Shah Rajeev M. Sale 151,803 30.34 4,606,158
2025-10-16 Hoffman Reid Sale 2,021 30.45 61,549
2025-10-15 Shah Rajeev M. Sale 51,363 30.86 1,585,062
2025-10-15 Hoffman Reid Sale 71,655 31.96 2,289,807
2025-10-14 Hoffman Reid Sale 33,668 30.32 1,020,780
2025-10-13 Hoffman Reid Sale 22,006 32.72 720,102
2025-10-10 Hoffman Reid Sale 40,983 30.97 1,269,120
2025-10-09 Hoffman Reid Sale 48,884 32.16 1,572,207
2025-10-08 Hoffman Reid Sale 75,262 34.05 2,562,370
2025-10-07 Hoffman Reid Sale 27,624 33.84 934,713
2025-10-06 Hoffman Reid Sale 70,763 36.97 2,615,825
2025-10-03 Hoffman Reid Sale 7,901 37.76 298,333
2025-10-02 Hoffman Reid Sale 32,451 39.52 1,282,495
2025-10-01 Hoffman Reid Sale 1,400 39.19 54,870
2025-09-16 Hoffman Reid Sale 447,278 1.54 688,808
2025-09-15 Hoffman Reid Sale 400,000 1.64 656,400
2025-09-12 Hoffman Reid Sale 300,000 1.75 526,200
2025-09-11 Hoffman Reid Sale 284,805 1.83 521,477
2025-09-10 Hoffman Reid Sale 350,000 1.81 635,250
2025-09-09 Hoffman Reid Sale 449,226 2.00 898,452
2025-09-08 Hoffman Reid Sale 464,421 1.99 924,197
2025-08-28 Hoffman Reid Sale 806,351 2.01 1,622,378
2025-08-27 Hoffman Reid Sale 611,647 2.00 1,226,352
2025-08-26 Hoffman Reid Sale 284,190 2.08 591,399
2025-08-25 Hoffman Reid Sale 387,346 2.12 819,624
2025-02-10 Attar Eyal C. (CHIEF MEDICAL OFFICER) Sale 2,554 1.37 3,498
2024-12-27 Attar Eyal C. (CHIEF MEDICAL OFFICER) Sale 10,334 1.25 12,917
2024-06-03 Attar Eyal C. (CHIEF MEDICAL OFFICER) Sale 14,645 1.39 20,356
2021-11-16 Parmar Kush (Director) Sale 330,706 15.30 5,059,801
2021-11-16 Schwab Andrew J. (10% Owner) Sale 330,706 15.30 5,059,801
2021-08-17 Chakraborty Tirtha (Chief Scientific Officer) Option Ex 17,446 1.36 23,726
2021-02-09 Parmar Kush (Director) Buy 555,555 18.00 9,999,990
2021-02-09 Shah Rajeev M. Buy 2,979,566 18.00 53,632,188
2021-02-09 Schwab Andrew J. (10% Owner) Buy 555,555 18.00 9,999,990

Insider trading activities including stock purchases, stock sales, and option exercises of VOR listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Vor Biopharma Inc. (symbol VOR, CIK number 1817229) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.